Chemical Component Summary

NameRASAGILINE
Identifiers(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine
FormulaC12 H13 N
Molecular Weight171.24
TypeNON-POLYMER
Isomeric SMILESC#CCN[C@@H]1CCc2ccccc12
InChIInChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1
InChIKeyRUOKEQAAGRXIBM-GFCCVEGCSA-N

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count1
Bond Count27
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB01367 
NameRasagiline
Groupsapproved
DescriptionRasagiline is an irreversible inhibitor of monoamine oxidase and is used as a monotherapy in early Parkinson's disease or as an adjunct therapy in more advanced cases.
Synonyms
  • (R)-N-2-Propynyl-1-indanamine
  • Rasagiline
  • RAS
  • (1R)-N-propargylindan-1-amine
  • (R)-indan-1-yl-prop-2-ynyl-amine
Brand Names
  • Azilect
  • Apo-rasagiline
  • Rasagiline Mesylate
  • Rasagiline Mylan
  • Rasagiline
IndicationFor the treatment of the signs and symptoms of idiopathic Parkinsons disease as initial monotherapy and as adjunct therapy to levodopa.
Categories
  • Agents that produce hypertension
  • Agents that reduce seizure threshold
  • Anti-Parkinson Drugs
  • Antidepressive Agents
  • Central Nervous System Agents
ATC-CodeN04BD02
CAS number136236-51-6

Drug Targets

NameTarget SequencePharmacological ActionActions
Amine oxidase [flavin-containing] BMSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQK...unknowninhibitor
Apoptosis regulator Bcl-2MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFS...unknownactivator
Cytochrome P450 1A2MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem3052776
ChEBICHEBI:63620
ChEMBLCHEMBL887
PharosCHEMBL887